Georgia Healthcare Group PLC announced changes to its Board of Directors with effect from 20 September 2018. The changes will further strengthen the Board's independence, reflecting its commitment to adhere to the highest standards of corporate governance. William (Bill) Huyett, an independent non-executive director, has been appointed as Chairman of GHG's Board of Directors. Bill replaces Irakli Gilauri, who will remain on the Board as a non-executive director. Fabian Blank joins the Board as an independent non-executive director. He has also been appointed as a member of the Clinical Quality and Safety and Nomination Committees and will join the Supervisory Board of JSC Georgia Healthcare Group. Ingeborg Oie has been appointed to the Audit Committee and has stepped down from the Clinical Quality and Safety Committee. Irakli Gilauri has stepped down from the Remuneration Committee, and Bill Huyett and Tim Elsigood have been appointed to the Nomination Committee. Mr. Huyett is the Chief Operating Officer of Ironwood Pharmaceuticals. Prior to that, during a 30-year career at McKinsey & Company Inc. in the US and Europe, he served clients in health care and other technology-intensive sectors. Mr. Blank is an entrepreneur, investor and senior management advisor in healthcare. He has operational leadership experience in healthcare services, and a strong background in digital health and technology. Mr. Blank is an early stage investor and founder in digital health, actively involved in a portfolio of patient-centric startups.